UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $80

UBS analyst Michael Yee has maintained a 'Buy' rating on Kodiak Sciences (NASDAQ: KOD) and increased the price target from $50 to $80. This adjustment reflects a positive outlook for the company's performance.